A systematic review of COVID-19 and the presentation of avoidant/restrictive food intake disorder and avoidant/restrictive food intake disorder-like symptoms.
Avoidant/restrictive food intake disorder
COVID-19
clinical presentation
eating disorders
prevalence
Journal
BJPsych open
ISSN: 2056-4724
Titre abrégé: BJPsych Open
Pays: England
ID NLM: 101667931
Informations de publication
Date de publication:
04 Mar 2024
04 Mar 2024
Historique:
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
epublish
Résumé
The adverse effects of COVID-19 and the associated restrictions on eating disorder populations have been discussed in recent literature. However, little is known about the presentation of cases with avoidant/restrictive food intake disorder (ARFID) during this period. To explore the extent of the literature on the presentation of ARFID, and ARFID-like cases, during the COVID-19 pandemic. Cochrane Library, CINAHL (EBSCO), PsycINFO (EBSCO), EMBASE (Ovid) and Medline (Ovid) were searched for publications between March 2020 and May 2023. Google Scholar and reference lists were hand searched. At least two reviewers independently screened each paper. Narrative synthesis was used. Seven papers were included: four case reports and three cohort studies (total ARFID sample of 46). Included papers were assessed as having high ( Publications specifically pertaining to ARFID presentations during the COVID-19 pandemic have been few. Papers found have been of small sample sizes and lack subanalyses for ARFID within broader eating disorder samples. Continued surveillance is needed to evaluate any COVID-19-specific effects on the development, identification, treatment and outcomes of ARFID.
Sections du résumé
BACKGROUND
BACKGROUND
The adverse effects of COVID-19 and the associated restrictions on eating disorder populations have been discussed in recent literature. However, little is known about the presentation of cases with avoidant/restrictive food intake disorder (ARFID) during this period.
AIMS
OBJECTIVE
To explore the extent of the literature on the presentation of ARFID, and ARFID-like cases, during the COVID-19 pandemic.
METHOD
METHODS
Cochrane Library, CINAHL (EBSCO), PsycINFO (EBSCO), EMBASE (Ovid) and Medline (Ovid) were searched for publications between March 2020 and May 2023. Google Scholar and reference lists were hand searched. At least two reviewers independently screened each paper. Narrative synthesis was used.
RESULTS
RESULTS
Seven papers were included: four case reports and three cohort studies (total ARFID sample of 46). Included papers were assessed as having high (
CONCLUSIONS
CONCLUSIONS
Publications specifically pertaining to ARFID presentations during the COVID-19 pandemic have been few. Papers found have been of small sample sizes and lack subanalyses for ARFID within broader eating disorder samples. Continued surveillance is needed to evaluate any COVID-19-specific effects on the development, identification, treatment and outcomes of ARFID.
Identifiants
pubmed: 38433590
doi: 10.1192/bjo.2023.655
pii: S2056472423006555
doi:
Types de publication
Journal Article
Review
Langues
eng